atherosclerosis l carnitine γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO Intestinal microbiota metabolism of l-carnitine,
Intestinal microbiota metabolism of l carnitine, a nutrient in red meat, promotes atherosclerosis Nature Medicine Frontiers Acetyl L carnitine ameliorates atherosclerosis in LDLR mice by modulating cholesterol metabolism through SREBP2 dependent cholesterol biosynthesis The origin of trimethylamine N oxide (TMAO) and its role in development of atherosclerosis Semantic Scholar Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism
Pay in 4 interest-free payments of $5.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



